These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9665012)

  • 21. Hyperacute skin allograft rejection in presensitized rats is abrogated by malononitrilamides.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1998 Jun; 30(4):963-7. PubMed ID: 9636390
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts.
    Vu MD; Qi S; Wang X; Jiang W; Ma A; Xu D; Bekersky I; Fitzsimmons WE; Wu J; Chen H
    Transplantation; 2003 May; 75(9):1455-9. PubMed ID: 12792496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat.
    Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
    Transplantation; 1993 Sep; 56(3):667-72. PubMed ID: 8212165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine.
    Williams JW; Xiao F; Foster P; Clardy C; McChesney L; Sankary H; Chong AS
    Transplantation; 1994 Apr; 57(8):1223-31. PubMed ID: 8178350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malononitrilamides prevent the generation of oxygen radicals in mononuclear phagocytes and graft rejection in a rat model.
    Schorlemmer HU; Bartlett RR; Kurrle R
    Transplant Proc; 1999; 31(1-2):851-3. PubMed ID: 10083371
    [No Abstract]   [Full Text] [Related]  

  • 27. Gangliosides potentiate the immunosuppressive effects of cyclosporin A in rat skin allografts.
    Sconocchia G; Ausiello CM; Spagnoli GC; Sciortino G; Filinger V; Giudiceandrea F; Cervelli V; Adorno D; Casciani CU
    Transpl Int; 1992; 5 Suppl 1():S544-6. PubMed ID: 14621872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leflunomide controls rejection in hamster to rat cardiac xenografts.
    Xiao F; Chong AS; Foster P; Sankary H; McChesney L; Koukoulis G; Yang J; Frieders D; Williams JW
    Transplantation; 1994 Oct; 58(7):828-34. PubMed ID: 7940718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of immunosuppressive efficacy by combining the novel leflunomide analog, HMR 279, with microemulsion cyclosporine in a rat lung transplant model.
    Hausen B; Boeke K; Berry GJ; Gummert JF; Christians U; Morris RE
    Transplantation; 1999 Feb; 67(3):354-9. PubMed ID: 10030278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergism of RAD and cyclosporin A in prevention of acute rat corneal allograft rejection.
    Reis A; Megahed M; Reinhard T; Godehardt E; Braunstein C; Sundmacher R
    Cornea; 2002 Jan; 21(1):81-4. PubMed ID: 11805513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of malononitriloamide 279 and 715 in islet xenotransplantation: a study in the pig-to-rat model.
    Wijkström M; Song Z; Zhang J; Bari S; Sundberg B; Groth CG; Korsgren O; Wennberg L
    Transplant Proc; 2000 Aug; 32(5):1024. PubMed ID: 10936331
    [No Abstract]   [Full Text] [Related]  

  • 34. Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation.
    Shen J; Chong AS; Xiao F; Liu W; Huang W; Blinder L; Foster P; Sankary H; Jensik S; McChesney L; Mital D; Williams JW
    Transplantation; 1998 Sep; 66(6):692-8. PubMed ID: 9771831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FK778 controls acute rejection after rat liver allotransplantation showing positive interaction with FK506.
    Yamamoto S; Okuda T; Yamasaki K; Tanaka H; Takemura S; Minamiyama Y; Ikeda K; Hirohashi K; Suehiro S
    Transplant Proc; 2005; 37(1):126-9. PubMed ID: 15808570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of antigen-dependent and antigen-independent factors on the development of graft vasculopathy in a fully allogeneic cardiac allograft model in the rat.
    Fiedel S; Bayer J; Schaub M; Heidt MC; Grebe M; Tillmanns H; Stadlbauer TH
    Transplant Proc; 2009; 41(6):2625-7. PubMed ID: 19715988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evaluation of combined immunosuppression with MNA 715 and microemulsified cyclosporine on renal allograft rejection in mismatched mongrel dogs.
    Kyles AE; Gregory CR; Griffey SM; Jackson J; Bernsteen L; Morris RE
    Vet Surg; 2002; 31(4):358-66. PubMed ID: 12094350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoral use in the cardiac transplant recipient.
    Valantine H
    Transplant Proc; 2000 May; 32(3A Suppl):27S-44S. PubMed ID: 10814748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.